Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12301866 | 0.93 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL12301863 | 0.91 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL177842 | 0.90 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL5465330 | 0.90 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL7795037 | 0.87 | ZDHHC20 (0.33) | ALDH1A1 | |
| SCHEMBL2445448 | 0.87 | — | — | |
| SCHEMBL7938767 | 0.87 | ZDHHC20 (0.33) | ALDH1A1 | |
| SCHEMBL2367646 | 0.87 | — | — | |
| SCHEMBL7929800 | 0.87 | ZDHHC20 (0.33) | ALDH1A1 | |
| SCHEMBL8724190 | 0.87 | ZDHHC20 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015577-A1 | COMPOSITION FOR 3D PRINTING SUPPORT OR 3D CELL CULTURE SUPPORT | JSR CORPORATION (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-0446636-B1 | External application base or auxiliary agent and external application composition for human being or animal containing the same | SHOWA DENKO KK (JP) | 1996-06-12 | — | — | EP | disclosed |
| US-5455042-A | Ointment comprising a homogenous mixture of a polymer or copolymer of N-vinylacetamide, water and/or alcohols, and a pharmacologically active component | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1995-10-03 | — | — | US | disclosed |
| US-5344655-A | Drug delivery | SHOWA DENKO K.K. (JP) | 1994-09-06 | — | — | US | disclosed |
| US-5254338-A | N-vinylacetamide polymer | SHOWA DENKO K.K. (JP) | 1993-10-19 | — | — | US | disclosed |
| EP-0446636-A2 | External application base or auxiliary agent and external application composition for human being or animal containing the same | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1991-09-18 | — | — | EP | disclosed |
| US-4916049-A | A SUPPORT HAVING AT LEAST TWO HYDROPHILIC COLLID LAYERS ONE OF WHICH IS DEXTRAN | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015577-A1 | COMPOSITION FOR 3D PRINTING SUPPORT OR 3D CELL CULTURE SUPPORT | BOD1L1, HTR3D, BPNT1 | ALDH1A1 1413/4885TSHR 4116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.